Abstract
For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.
Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles
Current Cancer Drug Targets
Title: Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Volume: 11 Issue: 2
Author(s): I. Ali
Affiliation:
Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles
Abstract: For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.
Export Options
About this article
Cite this article as:
Ali I., Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives, Current Cancer Drug Targets 2011; 11 (2) . https://dx.doi.org/10.2174/156800911794328457
DOI https://dx.doi.org/10.2174/156800911794328457 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BACE1 Structure and Function in Health and Alzheimers Disease
Current Alzheimer Research Fetal Determinants of Type 2 Diabetes
Current Drug Targets Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Anti-Cancer Agents in Medicinal Chemistry Does HbA1cc Play a Role in the Development of Cardiovascular Diseases?
Current Pharmaceutical Design Platelet Hyperreactivity and Stent Thrombosis in Patients Undergoing Coronary Stenting
Current Vascular Pharmacology Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Mining the Genome for Susceptibility to Complex Neurological Disorders
Current Molecular Medicine New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer’s Disease: A Phase 2, Open-Label Extension Study
Current Alzheimer Research Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Current Medicinal Chemistry High Blood Pressure and the Risk of Stroke
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
Current Neurovascular Research Atherosclerosis as an Inflammatory Disease
Current Pharmaceutical Design Clinical Value of Prostacyclin and its Analogs in the Management of Pulmonary Arterial Hypertension
Current Vascular Pharmacology Planar Cell Polarity Signaling in Collective Cell Movements During Morphogenesis and Disease
Current Genomics Coronary CT Angiography in the Diagnosis of Coronary Artery Disease
Current Medical Imaging Diabetic Cardiomyopathy and its Prevention by Metallothionein: Experimental Evidence, Possible Mechanisms and Clinical Implications
Current Medicinal Chemistry Anti-VEGF Therapy for Retinal Vein Occlusions
Current Drug Targets Nanoparticles: A Promising Therapeutic Approach in Atherosclerosis
Current Drug Delivery Heart Valve Lesions In The Antiphospholipid Syndrome
Current Rheumatology Reviews